Long Term Pharma Holds
Pharma industry has been doing well despite the recession, and I believe these companies will continue to do well moving forward (they have upcoming catalysts in q1/h1 2023)
1. $Viking Therapeutics(VKTX.US$ closest competitor to $Madrigal Pharmaceuticals(MDGL.US$ , which recently announced breakthroughs in the NASH space and price went up ×4 times. multiple catalysts in 2023 q1.
2. $ProQR Therapeutics(PRQR.US$ announced collaboration with LLY, their RNAI editing software is very novel and seems to be patented. LLY collaboration will help expedite its research, might be a future buyout canditate. Now might be too early to say, but in a few months time (when they announce their pipeline) or even years (looking at 2-3 years horizon) if all goes well this may hit 50++.
3. $PDS Biotechnology(PDSB.US$ sole license to itself, whereas large caps like $Moderna(MRNA.US$ dun even have.
Other mentions: $89bio(ETNB.US$ (nash industry), $Akero Therapeutics(AKRO.US$ (nash industry, price dropped in dec over safety concerns), $Beam Therapeutics(BEAM.US$ (hyped technology, will be interesting if can sustain the hype).
If your have other recommendations for biopharma pls add here also and Ill take a look. Hit me up if you want to talk about biopharma too
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
seeks out hidden stocks with high potential, loves spacs. chat with me about anything related to spacs
395Followers
23Following
1970Visitors
Follow
taijahmed75 : @ilovemoney29 what about $Heart Test Laboratories (HSCS.US)$ $Verastem (VSTM.US)$ $Scynexis (SCYX.US)$ $LumiraDx (LMDX.US)$ $InMed Pharmaceuticals (INM.US)$ $NRX Pharmaceuticals (NRXP.US)$ $Tracon Pharmaceuticals (TCON.US)$????